trending Market Intelligence /marketintelligence/en/news-insights/trending/5lm9igtnt2byafcjvews1w2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Northwest Biotherapeutics to raise $10M in direct offering

L.K. Bennett: Bankruptcy Case Study

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry


Northwest Biotherapeutics to raise $10M in direct offering

Northwest Biotherapeutics Inc. is selling 28.6 million common shares at 35 cents per share in a registered direct offering to institutional investors for gross proceeds of $10 million.

The investors will also receive warrants to buy up to about 14.3 million shares with an exercise price of 35 cents per share and an exercise period of five years.

The placement is expected to close on or about Dec. 23, subject to satisfaction of customary closing conditions.

Chardan Capital Markets LLC acted as the exclusive placement agent for the transaction.